Highlights and Quick Summary
- Annual Return on Tangible Assets for 2022 was -28.03% (a -306.1% decrease from previous year)
- Annual Return on Tangible Assets for 2021 was 13.6% (a -35.11% decrease from previous year)
- Annual Return on Tangible Assets for 2020 was 20.96% (a 289.59% increase from previous year)
- Twelve month Return on Tangible Assets ending June 30, 2023 was -126.67% (a 127.01% increase compared to previous quarter)
- Twelve month trailing Return on Tangible Assets decreased by -4021.67% year-over-year
Trailing Return on Tangible Assets for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -126.67% | -55.8% | -28.03% | 3.23% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Return on Tangible Assets of Emergent Biosolutions Inc.
Most recent Return on Tangible Assetsof EBS including historical data for past 10 years.Interactive Chart of Return on Tangible Assets of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Return on Tangible Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -28.03% |
| 2021 | – | – | – | – | 13.6% |
| 2020 | – | – | – | – | 20.96% |
| 2019 | – | – | – | – | 5.38% |
| 2018 | – | – | – | – | 6.74% |
| 2017 | – | – | – | – | 10.42% |
| 2016 | – | – | – | – | 6.63% |
| 2015 | – | – | – | – | 8.21% |
| 2014 | – | – | – | – | 5.62% |
| 2013 | – | – | – | – | 6.48% |
| 2012 | – | – | – | – | 5.31% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic